AU2003246252A1 - Drug delivery system of substituted hydroxypyridine compound and conjugate of hydroxypyridine compound - Google Patents

Drug delivery system of substituted hydroxypyridine compound and conjugate of hydroxypyridine compound

Info

Publication number: AU2003246252A1
Authority: AU; Australia
Prior art keywords: hydroxypyridine compound; conjugate; delivery system; drug delivery; substituted
Prior art date: 2002-07-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003246252A

Inventor

Mari Itoh

Kaori Kondo

Satoshi Matsumoto

Masashi MISE

Yasuyuki MIZUKI

Shunya Nakamura

Tomohiro Nigo

Naohiro Nishimura

Yasuhiro Teranishi

Hiroshi Toda

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sumitomo Pharma Co Ltd

Original Assignee

Dainippon Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-04

Filing date

2003-07-03

Publication date

2004-01-23

2003-07-03 Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd

2004-01-23 Publication of AU2003246252A1 publication Critical patent/AU2003246252A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/048—Pyridine radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Saccharide Compounds (AREA)

AU2003246252A 2002-07-04 2003-07-03 Drug delivery system of substituted hydroxypyridine compound and conjugate of hydroxypyridine compound Abandoned AU2003246252A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002195341A JP2006021996A (en)	2002-07-04	2002-07-04	Conjugated substance of substituted hydroxypyridine compound
JP2002-195341		2002-07-04
PCT/JP2003/008462 WO2004005259A1 (en)	2002-07-04	2003-07-03	Drug delivery system of substituted hydroxypyridine compound and conjugate of hydroxypyridine compound

Publications (1)

Publication Number	Publication Date
AU2003246252A1 true AU2003246252A1 (en)	2004-01-23

Family

ID=30112333

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003246252A Abandoned AU2003246252A1 (en)	2002-07-04	2003-07-03	Drug delivery system of substituted hydroxypyridine compound and conjugate of hydroxypyridine compound

Country Status (4)

Country	Link
JP (1)	JP2006021996A (en)
AU (1)	AU2003246252A1 (en)
TW (1)	TW200404540A (en)
WO (1)	WO2004005259A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9202464D0 (en) *	1992-02-05	1992-03-18	Danbiosyst Uk	Composition for nasal administration
RU2235095C2 (en) *	1998-10-06	2004-08-27	Дайниппон Фармасьютикал Ко., Лтд.	Disubstituted derivative of pyridine, methods for its preparing, pharmaceutical composition containing thereof and intermediate product for its preparing

2002
- 2002-07-04 JP JP2002195341A patent/JP2006021996A/en active Pending
2003
- 2003-07-03 AU AU2003246252A patent/AU2003246252A1/en not_active Abandoned
- 2003-07-03 WO PCT/JP2003/008462 patent/WO2004005259A1/en not_active Ceased
- 2003-07-04 TW TW092118415A patent/TW200404540A/en unknown

Also Published As

Publication number	Publication date
JP2006021996A (en)	2006-01-26
WO2004005259A1 (en)	2004-01-15
TW200404540A (en)	2004-04-01

Publication	Publication Date	Title
EP1545662B8 (en)	2020-05-20	Drug delivery system
AU2003211376A1 (en)	2003-09-09	Drug administration method
AU2002341959A1 (en)	2003-04-14	Drug delivery devices and methods
AU2319100A (en)	2000-08-18	Amide derivatives and drug compositions
AU2003287640A1 (en)	2004-06-03	Inertial drug delivery system
AU2003281876A1 (en)	2004-06-07	Pharmaceutical delivery systems and methods for using same
AU6271401A (en)	2001-12-24	Drug administering system and administering method
AU4357800A (en)	2000-11-02	Intracellular pharmaceutical targeting
AU1585601A (en)	2001-05-14	Transdermal administration of huperzine
AU2003222067A1 (en)	2003-10-13	System for delivery of therapeutic substances
AU2002353444A1 (en)	2003-05-19	Integrated transdermal drug delivery system
AU2002343555A1 (en)	2003-05-26	Eutectic-based self-nanoemulsified drug delivery system
AU3520900A (en)	2000-09-28	Implantable drug delivery system
AU2001238346A1 (en)	2001-08-27	Modification of biopolymers for improved drug delivery
GB0119012D0 (en)	2001-09-26	Transdermal delivery of drugs
AU2002353435A1 (en)	2004-06-30	Medication administration system
AU2002950853A0 (en)	2002-09-12	Aminopyrimidine compound and pharmaceutical use thereof
AU2003212962A1 (en)	2003-09-02	Transdermal drug delivery systems
AU2001270963A1 (en)	2002-02-13	Transdermal drug delivery system
AU2003258167A1 (en)	2003-10-13	Drug delivery particle
AU2003241134A1 (en)	2004-01-06	Transdermal drug delivery system
AU2002308649A1 (en)	2002-11-18	Compositions and methods for enhancing drug delivery
AU2003205322A1 (en)	2003-09-02	Device for transcutaneous drug delivery and uses therefor
AU3926000A (en)	2000-10-23	Methods and compositions for drug delivery
AU2003285550A1 (en)	2004-06-23	Drug delivery system

Legal Events

Date	Code	Title	Description
2005-04-07	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase